Angelo B. A. Laranjeira

IL-7 Contributes to the Progression of Human T-cell Acute Lymphoblastic Leukemias

Ana Silva, Angelo B. A. Laranjeira, Leila R. Martins et al. · Cancer Research · 2011 · 140 citations

Hematological Malignancy, Microenvironmental Factors, Autoimmune Disease +15

Potential Antileukemia Effect and Structural Analyses of SRPK Inhibition by N-(2-(Piperidin-1-yl)-5-(Trifluoromethyl)Phenyl)Isonicotinamide (SRPIN340)

Raoni Pais Siqueira, Éverton de Almeida Alves Barbosa, Marcelo D. Polêto et al. · PLoS ONE · 2015 · 77 citations · Full text

Pharmaceutical Science, Chemoprevention Strategy, Srpk Inhibition +19

Increased CCL2 and IL‐8 in the bone marrow microenvironment in acute lymphoblastic leukemia

Jaira F. de Vasconcellos, Angelo B. A. Laranjeira, Nilson Ivo Tonin Zanchin et al. · Pediatric Blood & Cancer · 2010 · 69 citations · Full text

DNA damage, demethylation and anticancer activity of DNA methyltransferase (DNMT) inhibitors

Angelo B. A. Laranjeira, Melinda G. Hollingshead, Dat Nguyen et al. · Scientific Reports · 2023 · 65 citations · Full text

Mouse lysine catabolism to aminoadipate occurs primarily through the saccharopine pathway; implications for pyridoxine dependent epilepsy (PDE)

Izabella A. Pena, Lygia Azevedo Marques, Angelo B. A. Laranjeira et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2016 · 59 citations

Neurophysiology, Medicine, Saccharopine Pathway +10